Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6846)
All Articles published online
|
Publishing Process of This Article
|
Aug 20, 2015 (publication date) through Dec 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Experimental Medicine
ISSN
2220-315x
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Digklia A, Voutsadakis IA. Eribulin for heavily pre-treated metastatic breast cancer patients. World J Exp Med 2015; 5(3): 194-199 [PMID: 26309821 DOI: 10.5493/wjem.v5.i3.194] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315X/full/v5/i3/194.htm |
| Number | Citing Articles |
| 1 |
Yasuko Kikuchi, Yoshihiro Uchida, Kazuo Shirakawa, Hajime Kanauchi, Takayoshi Niwa, Kotoe Nishioka, Keiichirou Tada, Masanori Hashimoto, Hidemitsu Yasuda, Ryoko Sugiura, Hidetaka Kawabata, Yasuyuki Seto, Toshihisa Ogawa. A multicenter, observational study of metastatic breast cancer patients who were treated with eribulin mesylate or taxane‐based regimens. Asia-Pacific Journal of Clinical Oncology 2018; 14(5) doi: 10.1111/ajco.12863
|
| 2 |
Erica Quaquarini, Federico Sottotetti, Daniela D’Ambrosio, Alberto Malovini, Stefania Morganti, Arianna Marinello, Lorenzo Pavesi, Mara Frascaroli. Eribulin across multiple lines of chemotherapy: a retrospective study on quality of life and efficacy in metastatic breast cancer patients. Future Oncology 2017; 13(sup11): 11 doi: 10.2217/fon-2016-0517
|
| 3 |
Ioannis A. Voutsadakis. A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer. Anti-Cancer Drugs 2017; 28(5): 557 doi: 10.1097/CAD.0000000000000493
|
| 4 |
Murat Sari, Pınar Saip. Eribulin monotherapy in heavily pretreated metastatic breast cancer patients in real life. Indian Journal of Cancer 2020; 57(1): 55 doi: 10.4103/ijc.IJC_458_18
|